(Reuters) -A U.S. federal judge has ruled that Lithium Americas Corp may conduct excavation work at its Thacker Pass lithium mine site in Nevada, denying a request from environmentalists who said the digging could harm sage grouse and other wildlife. The ruling marked a rare win for a U.S. critical minerals project as environmental groups increasingly pressure courts and regulators to block mining projects, even if they produce metals key to building electric vehicles. Chief Judge Miranda Du of the federal court in Reno, Nevada, said late on Friday that the digging - needed to determine whether the land holds historical import for Native Americans - may proceed while she determines the broader question of whether former President Donald Trump's administration erred when it approved the project in January.
The host city for Nio, Inc.'s (NYSE: NIO) annual gala event, where it customarily makes new product and services announcements, has been finalized. What Happened: Suzhou, a city located west of Shanghai, China's business capital, has been finalized to hold the fifth annual Nio Day, the CnEVPost reported. The choice of the host city marks the culmination of a multi-step process that includes the invitation of bids, shortlisting of cities based on preliminary surveys and voting of Nio users on the
Advocates say benefits haven't kept up with inflation — and that probably won't change.
(Bloomberg) -- China unveiled a sweeping overhaul of its $100 billion education tech sector, banning companies that teach the school curriculum from making profits, raising capital or going public.Beijing on Saturday published a plethora of regulations that together threaten to up-end the sector and jeopardize billions of dollars in foreign investment. Companies that teach school subjects can no longer accept overseas investment, which could include capital from the offshore registered entities
After an epic run following initial economic lockdowns (and a concurrent "market crash") last spring, stocks rallied and finished 2020 strong with double-digit percentage returns. Plus, buying shares of growing businesses is one way to beat the market when it does finally take a tumble. Three stocks you can start buying right now are Intuitive Surgical (NASDAQ: ISRG), Lemonade (NYSE: LMND), and Texas Instruments (NASDAQ: TXN).
There's also something else that I'm convinced about: Buying certain dividend stocks when the market crashes is a smart idea. You can lock in fantastic yields when you invest in the right dividend stocks that are trading at low prices. What are the best stocks to scoop up during a major market meltdown?
It's fair to say that Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) are dominating the coronavirus vaccine market these days. Their vaccines have fully immunized 86 million and 62 million Americans, respectively.
The market rally is back at highs, but Apple and other tech titans are on tap. Hold or sell Tesla stock before earnings?
Not only did the banking sector emerge from the pandemic largely unscathed, but the largest banks also endured three stress tests in a 12-month window to prove their durability for capital returns. KeyCorp and Fifth Third are among the names to consider.
Hundreds of Chinese companies are listed on U.S. markets. China is the world's most-populous nation and the second-largest economy with a booming urban middle class and amazing entrepreneurial activity. Often dozens of Chinese stocks are among the top performers at any given time, across an array of sectors.
At the moment, none seems to be stirring more of a buzz than inflation. Earlier this month, the Bureau of Labor Statistics reported that 12-month inflation, as measured by the Consumer Price Index for All Urban Consumers (CPI-U) was 5.4% in June 2021.
(Bloomberg) -- In the stock market, the refusal of retail investors to back down from every macro threat has become the only story. When will it end? Judging by the size of all the pools of cash lying around, it could be a while.Among all the economic stories of the pandemic, the one about money piling up in people’s accounts has been the most significant in the stock market, where the S&P 500 just notched its seventh gain in nine weeks. Money market accounts, viewed in some circles as a “dry po
Tesla second-quarter earnings will be very complicated. Figuring out if the stock will go up or down, however, shouldn't be.
Buyback announcements this year have already hit $431 billion, exceeding 2020’s $307 billion total. That number should continue to grow, and it could top the previous record of $1 trillion on a rolling 12-month basis.
Bank of America Corporation ( NYSE:BAC ) has announced that it will be increasing its dividend on the 24th of September...
Chipmakers Nvidia (NASDAQ: NVDA) and Micron Technology (NASDAQ: MU) have had very different experiences on the stock market so far in 2021, even though both companies have been delivering stellar results quarter after quarter. While Nvidia stock has handily beaten the market, Micron shares have remained nearly flat thus far. Is this a signal that investors should start dumping Micron stock and load up on Nvidia?
After last year's impressive rebound, the U.S. stock market has shown no signs of slowing down. On Friday, the S&P 500, Nasdaq Composite, and the Dow Jones Industrial Average all closed at record highs. Scott Levine (Hyzon Motors): If Hyzon Motors isn't a name you remember seeing among the other usual fuel cell suspects, it's not that surprising.
Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist?
Shares of Moderna (NASDAQ: MRNA) jumped 7.8% to a record closing high of $348.83 on Friday after European health officials recommended authorizing the drugmaker's coronavirus vaccine for kids 12 and older. The European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion on Moderna's vaccine. The European Commission will now consider granting authorization for use in adolescents.
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season. Big pharma companies, including Johnson & Johnson (NYSE: JNJ) and Novartis AG (NYSE: NVS) reported forecast-beating results and issued positive guidance. Preannouncements from the space were also largely positive. Moderna, Inc.'s (NASDAQ: MRNA) buoyancy spilled over into the week. The stoc